4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-047553
SVP & Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-08-26 | Option exercise | +30,000 | $16.31 | $489,300 | 152,872 | D |
| Derivatives | |||||||
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-08-26 | Option exercise · Stock Option | −30,000 | 57,500 | D | ||
Loading xslF345X03/doc4.xml…